Literature DB >> 12923847

Highly enantioselective construction of quaternary stereocenters on beta-keto esters by phase-transfer catalytic asymmetric alkylation and Michael reaction.

Takashi Ooi1, Takashi Miki, Mika Taniguchi, Misato Shiraishi, Mifune Takeuchi, Keiji Maruoka.   

Abstract

Entities:  

Year:  2003        PMID: 12923847     DOI: 10.1002/anie.200351469

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  6 in total

1.  Enantioselective Intermolecular Pd-Catalyzed Hydroalkylation of Acyclic 1,3-Dienes with Activated Pronucleophiles.

Authors:  Nathan J Adamson; Katherine C E Wilbur; Steven J Malcolmson
Journal:  J Am Chem Soc       Date:  2018-02-20       Impact factor: 15.419

2.  Catalytic enantioselective claisen rearrangements of O-allyl β-ketoesters.

Authors:  Christopher Uyeda; Andreas R Rötheli; Eric N Jacobsen
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-10       Impact factor: 15.336

3.  Asymmetric addition of α-branched cyclic ketones to allenamides catalyzed by a chiral phosphoric acid.

Authors:  Xiaoyu Yang; F Dean Toste
Journal:  Chem Sci       Date:  2016-01-19       Impact factor: 9.825

4.  Brønsted acid and Pd-PHOX dual-catalysed enantioselective addition of activated C-pronucleophiles to internal dienes.

Authors:  Sangjune Park; Nathan J Adamson; Steven J Malcolmson
Journal:  Chem Sci       Date:  2019-04-17       Impact factor: 9.825

5.  H-Bond Mediated Phase-Transfer Catalysis: Enantioselective Generating of Quaternary Stereogenic Centers in β-Keto Esters.

Authors:  Patryk Niedbała; Maciej Majdecki; Piotr Grodek; Janusz Jurczak
Journal:  Molecules       Date:  2022-04-13       Impact factor: 4.927

6.  Enantioselective Synthesis of Acyclic Orthogonally Functionalized Compounds Bearing a Quaternary Stereocenter Using Chiral Ammonium Salt Catalysis.

Authors:  Katharina Röser; Bettina Berger; Michael Widhalm; Mario Waser
Journal:  ChemistryOpen       Date:  2021-08       Impact factor: 2.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.